News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Illumina (ILMN) Introduces A New Genomic Era



8/9/2017 6:35:04 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Illumina's (NASDAQ:ILMN) second-quarter earnings crushed expectations last week. Investors cheered the company's raised guidance, and the stock is up more than 15% since the report.

Illumina's genomic sequencing machines read the As, Cs, Ts, and Gs of a human being's DNA and then digitizes them into a format that can be easily understood. One of the most exciting developments in the company's recent history was the introduction earlier this year of its newest NovaSeq model. NovaSeq has the potential to bring the cost of a human genome sequence down to $100, which would be a tenfold reduction from where we stand today.

Read at Motley Fool


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES